Easterly Investment Partners LLC Collegium Pharmaceutical, Inc Transaction History
Easterly Investment Partners LLC
- $1.25 Billion
- Q4 2024
A detailed history of Easterly Investment Partners LLC transactions in Collegium Pharmaceutical, Inc stock. As of the latest transaction made, Easterly Investment Partners LLC holds 56,158 shares of COLL stock, worth $1.68 Million. This represents 0.13% of its overall portfolio holdings.
Number of Shares
56,158
Previous 56,158
-0.0%
Holding current value
$1.68 Million
Previous $2.17 Million
25.86%
% of portfolio
0.13%
Previous 0.18%
Shares
10 transactions
Others Institutions Holding COLL
# of Institutions
247Shares Held
37.4MCall Options Held
59.3KPut Options Held
9.5K-
Black Rock Inc. New York, NY5.79MShares$173 Million0.0% of portfolio
-
Eventide Asset Management, LLC Boston, MA2.64MShares$79 Million1.45% of portfolio
-
Rubric Capital Management LP New York, NY2.35MShares$70.3 Million1.11% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.28MShares$68.3 Million0.0% of portfolio
-
Pacer Advisors, Inc. Malvern, PA2.14MShares$64.1 Million0.15% of portfolio
About COLLEGIUM PHARMACEUTICAL, INC
- Ticker COLL
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 34,126,200
- Market Cap $1.02B
- Description
- Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...